Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling

被引:67
作者
Helman, D
Sandowski, Y
Cohen, Y
Matsumoto, A
Yoshimura, A
Merchav, S
Gertler, A [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel
[2] Kurume Univ, Inst Life Sci, Kurume, Fukuoka 839, Japan
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Anat & Cell Biol, Haemopoiesis Unit, IL-31096 Haifa, Israel
来源
FEBS LETTERS | 1998年 / 441卷 / 02期
关键词
cytokine-inducible SH2 protein; JAK2 binding protein; prolactin receptor; inhibition; cytokine signaling;
D O I
10.1016/S0014-5793(98)01555-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of five members of the cytokine-inducible SH2 protein family (CIS1-4) and JAK2 binding (JAB) protein to affect prolactin receptor (PRLR)-mediated activity was tested in human 293 embryonic kidney fibroblasts transiently transfected with rat PRLR, five concentrations of CIS/JAB Myc-tagged cDNAs and a STAT5-responsive reporter gene encoding luciferase, The protein expressions of CIS1, CIS2, CIS3 and JAB were comparable, whereas the level of CIS4 was slightly lon er. PRLR-mediated luciferase activity was abolished in a dose-dependent manner in cells transfected with cDNA of CIS3 or JAB, even at concentrations below the level of protein detection by anti-Myc antibody, In contrast, CIS1, CIS2 and CIS4 had little or no effect, despite similar levels of expression, CIS1 expression in postpartum mouse mammary glands was high and changed little in the course of 3 days, CIS2 and CIS3 expression was also high and increased further, whereas JAB expression was very low. These results hint that at least in mammary gland CIS3 is likely the main physiological negative regulator of the PRLR-mediated JAK2/STAT5 pathway. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 37 条
  • [1] Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
    Adams, TE
    Hansen, JA
    Starr, R
    Nicola, NA
    Hilton, DJ
    Billestrup, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1285 - 1287
  • [2] PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation
    Ali, S
    Chen, ZJ
    Lebrun, JJ
    Vogel, W
    Kharitonenkov, A
    Kelly, PA
    Ullrich, A
    [J]. EMBO JOURNAL, 1996, 15 (01) : 135 - 142
  • [3] Cytokine signaling: Cytokine-inducible signaling inhibitors
    Aman, NJ
    Leonard, WJ
    [J]. CURRENT BIOLOGY, 1997, 7 (12) : R784 - R788
  • [4] Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
    Auernhammer, CJ
    Chesnokova, V
    Bousquet, C
    Melmed, S
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) : 954 - 961
  • [5] PROLACTIN RECEPTOR IS ASSOCIATED WITH C-SRC KINASE IN RAT-LIVER
    BERLANGA, JJ
    VARA, JAF
    MARTINPEREZ, J
    GARCIARUIZ, JP
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (11) : 1461 - 1467
  • [6] Identification of SOCS-3 as a potential mediator of central leptin resistance
    Bjorbaek, C
    Elmquist, JK
    Frantz, JD
    Shoelson, SE
    Flier, JS
    [J]. MOLECULAR CELL, 1998, 1 (04) : 619 - 625
  • [7] Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
    Bole-Feysot, C
    Goffin, V
    Edery, M
    Binart, N
    Kelly, PA
    [J]. ENDOCRINE REVIEWS, 1998, 19 (03) : 225 - 268
  • [8] Involvement of a subset of tyrosine kinases and phosphatases in regulation of the beta-lactoglobulin gene promoter by prolactin
    Daniel, N
    Waters, MJ
    Bignon, C
    Djiane, J
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 118 (1-2) : 25 - 35
  • [9] Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
    Dey, BR
    Spence, SL
    Nissley, P
    Furlanetto, RW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 24095 - 24101
  • [10] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924